10 studies were found.

1.		Not yet recruiting	Comparative Trial between Bexxar and Zevalin Conditions: Follicular Lymphoma; Diffuse Large Cell Lymphoma
2.		No longer recruiting	Expanded Access Study of Iodine-131 Anti-B1 Antibody Condition: Non-Hodgkin's Lymphoma
3.		Recruiting	Pharmacokinetic Study of Previously Untreated, Relapsed, or Transformed Follicular Non-Hodgkin's Lymphoma with Fission-Derived Iodine I 131 Tositumomab Condition: Non-Hodgkin's Lymphoma
4.		No longer recruiting	Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade non-Hodgkin's Lymphoma Following First Line CHOP Condition: Non-Hodgkin's Lymphoma
5.		No longer recruiting	Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement Condition: Non-Hodgkin's Lymphoma
6.		No longer recruiting	Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia Condition: Chronic Lymphocytic Leukemia
7.		No longer recruiting	Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma Condition: Non-Hodgkin's Lymphoma
8.		Recruiting	Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma Condition: Mantle Cell Lymphoma
9.		Recruiting	Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer Condition: Non-small cell lung cancer
10.		Recruiting	A Study of Rituximab versus Iodine I 131 Tositumomab Therapy for Patients with Non-Hodgkin's Lymphoma Condition: Non-Hodgkin's Lymphoma